Relevance of first-line drugs for treatment of multiple sclerosis in present-day conditions-Reference-Cited by-同舟云学术

Relevance of first-line drugs for treatment of multiple sclerosis in present-day conditions

Published:2020-12-10 Issue:19 Volume: Page:62-68
ISSN:2658-5790
Container-title:Meditsinskiy sovet = Medical Council
language:
Short-container-title:Medicinskij sovet

Author:

Lashch N. Yu.¹^ORCID

Affiliation:

1. Pirogov Russian National Research Medical University

Publisher

Remedium, Ltd.

Subject

General Medicine

Reference28 articles.

1. Browne P., Chandraratna D., Angood C., Baker C., Taylor B.V., Thompson AJ. Atlas of Multiple Sclerosis 2013: a growing global problem with widespread inequity. Neurology. 2014;83(11):1022-1024. doi: 10.1212/WNL.0000000000000768.

2. Zakharova M.N. (ed.). Multiple sclerosis: issues of diagnosis and treatment. Moscow: Media Mente; 2018. 240 p. (In Russ.) Available at: https://www.mmbook.ru/catalog/newrologija/neurologyo/110022-detail.

3. Gusev E.I., Zavalishin I.A., Boyko A.N. (eds.). Multiple sclerosis. Moscow: Real Taym; 2011. 528 p. (In Russ.) Available at: https://www.neurology.ru/ras-seyannyy-skleroz.

4. Noseworthy J.H., Lucchinetti C., Rodriguez M., Weinshenker B.G. Multiple sclerosis. N Engl J Med. 2000;343(13):938-952. doi: 10.1056/NEJM200009283431307.

5. Thompson AJ., Banwell B.L., Barchof F., Caroll W.M., Coetzee T., Comi G. et al. Diagnosis of multiple sclerosis: 2017 revision of the McDonald criteria. Lancet Neurol. 2018;17(2):162-173. doi: 10.1016/S1474-4422(17)30470-2.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term treatment for multiple sclerosis with interferon beta-1b. Outcomes of an open, retrospective, observational study;Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova;2022